DK529885D0 - Farmaceutiske kapsler med langvarig frigivelse - Google Patents

Farmaceutiske kapsler med langvarig frigivelse

Info

Publication number
DK529885D0
DK529885D0 DK529885A DK529885A DK529885D0 DK 529885 D0 DK529885 D0 DK 529885D0 DK 529885 A DK529885 A DK 529885A DK 529885 A DK529885 A DK 529885A DK 529885 D0 DK529885 D0 DK 529885D0
Authority
DK
Denmark
Prior art keywords
long
term release
caps
pharmaceutical
pharmaceutical caps
Prior art date
Application number
DK529885A
Other languages
English (en)
Other versions
DK529885A (da
Inventor
S R Kalidindi
R P Giannini
J L Gaskill
E J Russo
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of DK529885A publication Critical patent/DK529885A/da
Publication of DK529885D0 publication Critical patent/DK529885D0/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK529885A 1984-03-21 1985-11-15 Farmaceutiske kapsler med langvarig frigivelse DK529885D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59173884A 1984-03-21 1984-03-21
PCT/US1985/000300 WO1985004100A1 (en) 1984-03-21 1985-02-22 Sustained release pharmaceutical capsules

Publications (2)

Publication Number Publication Date
DK529885A DK529885A (da) 1985-11-15
DK529885D0 true DK529885D0 (da) 1985-11-15

Family

ID=24367713

Family Applications (1)

Application Number Title Priority Date Filing Date
DK529885A DK529885D0 (da) 1984-03-21 1985-11-15 Farmaceutiske kapsler med langvarig frigivelse

Country Status (13)

Country Link
EP (1) EP0156592A3 (da)
JP (1) JPS61501511A (da)
KR (1) KR850700212A (da)
AU (1) AU4064285A (da)
DK (1) DK529885D0 (da)
ES (1) ES8700935A1 (da)
FI (1) FI854573A (da)
GB (1) GB2157169A (da)
GR (1) GR850625B (da)
HU (1) HUT38262A (da)
PT (1) PT80124B (da)
WO (1) WO1985004100A1 (da)
ZA (1) ZA851891B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2176999B (en) * 1985-06-22 1989-07-12 Stanley Stewart Davis Sustained release medicament
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
GB8624213D0 (en) * 1986-10-09 1986-11-12 Sandoz Canada Inc Sustained release pharmaceutical compositions
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
SI8710406B (sl) * 1987-03-11 1998-08-31 Lek Tablete s podaljšanim delovanjem na osnovi hidroksipropilmetilceluloze z veliko molsko maso in postopek za njihovo pripravo
FR2618073B1 (fr) * 1987-07-16 1990-09-07 Pf Medicament Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation
IT1222414B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Composizioni farmaceutiche contenenti trapidil,loro procedimento di preparazione e relaticvo impiego terapeutico
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
IL123505A (en) 1996-07-08 2004-12-15 Penwest Pharmaceuticals Compan Sustained release matrix for high-dose insoluble drugs
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US20070264346A1 (en) * 2006-02-16 2007-11-15 Flamel Technologies Multimicroparticulate pharmaceutical forms for oral administration
JP5699339B2 (ja) * 2010-02-12 2015-04-08 日産化学工業株式会社 徐放性製剤
US8999393B1 (en) * 2013-01-09 2015-04-07 Edgemont Pharmaceuticals Llc Sustained release formulations of lorazepam
MX2015008757A (es) * 2013-01-09 2016-02-05 Edgemont Pharmaceuticals Llc Formulaciones de lorazepam de liberacion controlada.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3427378A (en) * 1965-02-12 1969-02-11 American Cyanamid Co Sustained release encapsulated formula
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.

Also Published As

Publication number Publication date
GB2157169A (en) 1985-10-23
FI854573A0 (fi) 1985-11-20
HUT38262A (en) 1986-05-28
DK529885A (da) 1985-11-15
KR850700212A (ko) 1985-12-26
EP0156592A3 (en) 1987-03-11
ES541394A0 (es) 1986-11-16
ES8700935A1 (es) 1986-11-16
JPS61501511A (ja) 1986-07-24
AU4064285A (en) 1985-10-11
EP0156592A2 (en) 1985-10-02
GR850625B (da) 1985-06-17
PT80124B (en) 1986-11-14
PT80124A (en) 1985-04-01
FI854573A (fi) 1985-11-20
ZA851891B (en) 1986-10-29
GB8506656D0 (en) 1985-04-17
WO1985004100A1 (en) 1985-09-26

Similar Documents

Publication Publication Date Title
DK529885A (da) Farmaceutiske kapsler med langvarig frigivelse
MX163529B (es) Composicion quimicoluminiscente
DK166010C (da) Sutenhed med taetnende nippel
DK403885D0 (da) Bloedgoeringsmiddelholdigt vaskemiddel med forbedret substantivitet
IT1209615B (it) Composizione farmaceutica
IT1213453B (it) Composizione farmaceutica.
DK168586D0 (da) Acaricide thiadiazoler
DK453785D0 (da) Laegemiddel med grf-virkning
DK499986D0 (da) Farmaceutisk praeparat med antibakteriel virkning
DK10387D0 (da) Langvarigt virkende antacidt praeparat langvarigt virkende antacidt praeparat
ES289264Y (es) Gorra deportiva perfeccionada
SE8405385D0 (sv) Drug release device
SE8404012D0 (sv) Diskhopase med hallare
RO90578A2 (ro) Produs medicamentos fitoterapeutic hepatoprotector
SE8400086D0 (sv) Farmaceutisk komposition
BR6500407U (pt) Composicao medicinal
ES291076Y (es) Gorra perfeccionada
BR8500100A (pt) Calota aperfeicoada
SE8404468D0 (sv) Farmaceutisk beredning
LV5081A3 (lv) Herbicida kompozicija
RO91784A2 (ro) Compozitie tananta
RO93284A2 (ro) Compozitie rodenticida
RO93894A (ro) Compozitie erbicida sinergetica
SE8406003D0 (sv) Langstreckt foremal
IT8520738V0 (it) Visiere parafaccia

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment